M Greenhawt1, D M Fleischer1, E S Chan2, C Venter3, D Stukus4, R Gupta5, J M Spergel6. 1. Department of Pediatrics, Section of Allergy, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA. 2. Division of Allergy and Immunology, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada. 3. Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 4. Department of Pediatrics, Section of Allergy and Immunology, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH, USA. 5. Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern Medicine, Chicago, IL, USA. 6. Division of Allergy-Immunology, Department of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA.
Abstract
BACKGROUND: In the Learning Early About Peanut Allergy (LEAP) study, early peanut introduction in high-risk 4- to 11-month-olds was associated with a significantly decreased risk of developing peanut allergy. However, the influences of key baseline high-risk factors on peanut tolerance are poorly understood. METHODS: Secondary analysis was conducted on the publically available LEAP dataset, exploring relationships between peanut tolerance, baseline peanut/egg sensitization, eczema severity/duration, age of introduction, gender, and race. RESULTS: A multiple logistic regression model predicting odds of successful oral food challenge (OFC) at 60 months noted higher odds with early introduction (OR 9.2, P < 0.001, 95% CI 4.2-20.3), white race (OR 2.1, P = 0.04, 95% CI 1.1-3.9), and advancing age (OR 4.8, P = 0.04, 95% CI 1.1-20.8). Odds of peanut tolerance were lower with increasing peanut wheal size (OR 0.58, P < 0.001, 95% CI 0.46-0.74), increased baseline SCORAD score (OR 0.98, P = 0.04, 95% CI 0.97-1), and increased kUA /l of egg serum IgE (sIgE) (OR 0.99, P = 0.04, 95% CI 0.98-1). The probability of peanut tolerance in the early introduction group was 83% vs 43% in the avoidance group with SPT wheal of <4 mm. The probability of a successful OFC was significantly higher with peanut introduction between 6 and 11 months than at 4-6 months. Increasing eczema severity had limited impact on the probability of peanut tolerance in the early introduction arm. CONCLUSION: Increasing peanut wheal size predicted peanut tolerance only in the avoidance arm. Peanut introduction between 6 and 11 months of age was associated with the highest rates of peanut tolerance, questioning the 'urgency' of introduction before 6 months.
BACKGROUND: In the Learning Early About PeanutAllergy (LEAP) study, early peanut introduction in high-risk 4- to 11-month-olds was associated with a significantly decreased risk of developing peanutallergy. However, the influences of key baseline high-risk factors on peanut tolerance are poorly understood. METHODS: Secondary analysis was conducted on the publically available LEAP dataset, exploring relationships between peanut tolerance, baseline peanut/egg sensitization, eczema severity/duration, age of introduction, gender, and race. RESULTS: A multiple logistic regression model predicting odds of successful oral food challenge (OFC) at 60 months noted higher odds with early introduction (OR 9.2, P < 0.001, 95% CI 4.2-20.3), white race (OR 2.1, P = 0.04, 95% CI 1.1-3.9), and advancing age (OR 4.8, P = 0.04, 95% CI 1.1-20.8). Odds of peanut tolerance were lower with increasing peanut wheal size (OR 0.58, P < 0.001, 95% CI 0.46-0.74), increased baseline SCORAD score (OR 0.98, P = 0.04, 95% CI 0.97-1), and increased kUA /l of egg serum IgE (sIgE) (OR 0.99, P = 0.04, 95% CI 0.98-1). The probability of peanut tolerance in the early introduction group was 83% vs 43% in the avoidance group with SPT wheal of <4 mm. The probability of a successful OFC was significantly higher with peanut introduction between 6 and 11 months than at 4-6 months. Increasing eczema severity had limited impact on the probability of peanut tolerance in the early introduction arm. CONCLUSION: Increasing peanut wheal size predicted peanut tolerance only in the avoidance arm. Peanut introduction between 6 and 11 months of age was associated with the highest rates of peanut tolerance, questioning the 'urgency' of introduction before 6 months.
Authors: Jennifer J Koplin; Nicholas J Osborne; Melissa Wake; Pamela E Martin; Lyle C Gurrin; Marnie N Robinson; Dean Tey; Marjolein Slaa; Leone Thiele; Lucy Miles; Deborah Anderson; Tina Tan; Thanh D Dang; David J Hill; Adrian J Lowe; Melanie C Matheson; Anne-Louise Ponsonby; Mimi L K Tang; Shyamali C Dharmage; Katrina J Allen Journal: J Allergy Clin Immunol Date: 2010-10 Impact factor: 10.793
Authors: Nicholas J Osborne; Jennifer J Koplin; Pamela E Martin; Lyle C Gurrin; Adrian J Lowe; Melanie C Matheson; Anne-Louise Ponsonby; Melissa Wake; Mimi L K Tang; Shyamali C Dharmage; Katrina J Allen Journal: J Allergy Clin Immunol Date: 2011-03 Impact factor: 10.793
Authors: Ruchi S Gupta; Elizabeth E Springston; Manoj R Warrier; Bridget Smith; Rajesh Kumar; Jacqueline Pongracic; Jane L Holl Journal: Pediatrics Date: 2011-06-20 Impact factor: 7.124
Authors: Hugh A Sampson; Seema Aceves; S Allan Bock; John James; Stacie Jones; David Lang; Kari Nadeau; Anna Nowak-Wegrzyn; John Oppenheimer; Tamara T Perry; Christopher Randolph; Scott H Sicherer; Ronald A Simon; Brian P Vickery; Robert Wood; David Bernstein; Joann Blessing-Moore; David Khan; David Lang; Richard Nicklas; John Oppenheimer; Jay Portnoy; Christopher Randolph; Diane Schuller; Sheldon Spector; Stephen A Tilles; Dana Wallace; Hugh A Sampson; Seema Aceves; S Allan Bock; John James; Stacie Jones; David Lang; Kari Nadeau; Anna Nowak-Wegrzyn; John Oppenheimer; Tamara T Perry; Christopher Randolph; Scott H Sicherer; Ronald A Simon; Brian P Vickery; Robert Wood Journal: J Allergy Clin Immunol Date: 2014-08-28 Impact factor: 10.793
Authors: Supinda Bunyavanich; Sheryl L Rifas-Shiman; Thomas A E Platts-Mills; Lisa Workman; Joanne E Sordillo; Matthew W Gillman; Diane R Gold; Augusto A Litonjua Journal: J Allergy Clin Immunol Date: 2014-07-30 Impact factor: 10.793
Authors: C Venter; S Hasan Arshad; J Grundy; B Pereira; C Bernie Clayton; K Voigt; B Higgins; T Dean Journal: Allergy Date: 2010-01 Impact factor: 13.146
Authors: Scott H Sicherer; Robert A Wood; Tamara T Perry; Stacie M Jones; Donald Y M Leung; Alice K Henning; Peter Dawson; A Wesley Burks; Robert Lindblad; Hugh A Sampson Journal: Allergy Date: 2019-07-15 Impact factor: 13.146
Authors: Matthew T Walker; Jeremy E Green; Ryan P Ferrie; Ashley M Queener; Mark H Kaplan; Joan M Cook-Mills Journal: J Allergy Clin Immunol Date: 2018-02-15 Impact factor: 10.793
Authors: K Lawson; H T Bahnson; E Brittain; M Sever; G Du Toit; G Lack; C Keet; M Greenhawt; D Fleischer; E S Chan; C Venter; D Stukus; R Gupta; J Spergel Journal: Allergy Date: 2017-08 Impact factor: 13.146
Authors: Lauren M Buelow; Akihiko Hoji; Kiet Tat; Lindsay M Schroeder-Carter; Daniela J Carroll; Joan M Cook-Mills Journal: Front Allergy Date: 2021-09-06
Authors: Michael G Sherenian; Arjun Kothari; Jocelyn M Biagini; John W Kroner; Asel Baatyrbek Kyzy; Elisabet Johannson; Gowtham Atluri; Hua He; Lisa J Martin; Gurjit K Khurana Hershey Journal: Clin Exp Allergy Date: 2021-03-21 Impact factor: 5.401